Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Posten Norge in conjunction with the sale of Frigoscandia
Mandate

Vinge advises Posten Norge in conjunction with the sale of Frigoscandia

November 19, 2021 M&A

Vinge has advised Posten Norge in conjunction with the sale of the wholly owned subsidiary Frigoscandia to the German company Mutares. Frigoscandia is market leading in temperature-controlled logistics in Sweden and operates an international network in Sweden, Denmark, Finland, the Netherlands, France and Norway.

The group has a turnover of approximately SEK 2.5 billion and employs around 1,000 people. The transaction is subject to the customary competition approval.

Vinge’s team primarily consisted of Johan Winnerblad, Desirée Hagenfeldt, Viktor Lennartsson, Klara Lundquist and Cathrin Larsson.

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025